Evaluation of biomarkers and surrogate endpoints in chronic disease /
"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in ord...
Saved in:
Corporate Author: | Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |
---|---|
Other Authors: | Micheel, Christine, Ball, John, 1944- |
Format: | Electronic eBook |
Language: | English |
Published: |
Washington, D.C. :
National Academies Press,
©2010.
|
Series: | Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf. |
Subjects: | |
Online Access: | CONNECT |
Similar Items
-
Perspectives on biomarker and surrogate endpoint evaluation : discussion forum summary /
by: Mack, Alison, et al.
Published: (2011) -
Biomarkers of disease : an evidence-based approach /
Published: (2002) -
The path from biomarker discovery to regulatory qualification /
by: Goodsaid, Federico
Published: (2013) -
Biomarkers in toxicology /
Published: (2019) -
Biomarkers in toxicology /
Published: (2014)